Combination of ALpelisib and Trametinib in progressive REfractory Meningiomas

Status

Recruiting

Phases

Phase 1

Study type

Interventional

Source

EU CTIS

Registry ID

CTIS2024-515836-61-00

Enrollment

Registered

2024-08-14

Start date

2019-09-30

Completion date

Unknown

Last updated

2025-03-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Menangiomas

None listed

Sex/Gender

All

Age

18 Years to No maximum

France

None listed

Source: EU CTIS · Data processed: Feb 4, 2026